Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe Publications section now clarifies that entries are automatically filled from PubMed and may not pertain to the study, and the revision tag was updated to v3.3.2, replacing the previous PubMed-derived description. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check36 days agoChange DetectedAdded sections/links for the Moffitt Cancer Center Clinical Trials website, the H. Lee Moffitt Cancer Center and Research Institute, and Helpful Links Provided by H. Lee Moffitt Cancer Center and Research Institute to the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page content is essentially unchanged between versions; only minor layout adjustments and an updated last update date are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange Detected- Updated page version to v3.2.0; added a government operating-status notice. - Removed resource: Cutaneous neuroendocrine carcinoma (no longer listed).SummaryDifference4%

- Check79 days agoChange DetectedUpdate to reflect newer dates and a newer revision (v3.1.0) while removing older timestamps and the previous revision (v3.0.2).SummaryDifference0.6%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.